Sulfaguanidine-13C6, a premium pharmaceutical research compound designed for advanced antibacterial and antimicrobial studies. As an isotopically labeled analog of Sulfaguanidine, it offers enhanced stability and precise isotopic tracking. Sulfaguanidine-13C6 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel antimicrobial therapies. Trusted by leading laboratories, Sulfaguanidine-13C6 is your go-to solution for cutting-edge antibacterial research. Unlock new possibilities in infection treatment with Sulfaguanidine-13C6, where innovation meets reliability.
| Catalog Number | S000242 |
| Molecular Formula | C13C6H10N4O2S |
| Purity | 95% |
| IUPAC Name | 2-(4-amino(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)sulfonylguanidine |
| InChI | InChI=1S/C7H10N4O2S/c8-5-1-3-6(4-2-5)14(12,13)11-7(9)10/h1-4H,8H2,(H4,9,10,11)/i1+1,2+1,3+1,4+1,5+1,6+1 |
| InChIKey | BRBKOPJOKNSWSG-IDEBNGHGSA-N |
| SMILES | [13CH]1=[13CH][13C](=[13CH][13CH]=[13C]1N)S(=O)(=O)N=C(N)N |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. LOWELL A, et, al. THE USE OF SULFAGUANIDINE IN THE TREATMENT OF DYSENTERY CARRIERS. JAMA. 1942 Apr; 118(15):1268-1271. [3]. Mizuno N, et, al. Gastrointestinal absorption of sulfaguanidine in neonatal and adult rats. J Pharmacobiodyn. 1986 Oct;9(10):787-92. |
